These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36607480)
61. Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Adhami VM; Aziz MH; Reagan-Shaw SR; Nihal M; Mukhtar H; Ahmad N Mol Cancer Ther; 2004 Aug; 3(8):933-40. PubMed ID: 15299076 [TBL] [Abstract][Full Text] [Related]
62. Ring-substituted analogs of 3,3'-diindolylmethane (DIM) induce apoptosis and necrosis in androgen-dependent and -independent prostate cancer cells. Goldberg AA; Titorenko VI; Beach A; Abdelbaqi K; Safe S; Sanderson JT Invest New Drugs; 2014 Feb; 32(1):25-36. PubMed ID: 23709189 [TBL] [Abstract][Full Text] [Related]
63. AZD1152-HQPA induces growth arrest and apoptosis in androgen-dependent prostate cancer cell line (LNCaP) via producing aneugenic micronuclei and polyploidy. Zekri A; Ghaffari SH; Ghanizadeh-Vesali S; Yaghmaie M; Salmaninejad A; Alimoghaddam K; Modarressi MH; Ghavamzadeh A Tumour Biol; 2015 Feb; 36(2):623-32. PubMed ID: 25277659 [TBL] [Abstract][Full Text] [Related]
64. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA]. Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562 [TBL] [Abstract][Full Text] [Related]
66. Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis. Raclaw KA; Heemers HV; Kidd EM; Dehm SM; Tindall DJ Prostate; 2008 Nov; 68(15):1696-706. PubMed ID: 18726983 [TBL] [Abstract][Full Text] [Related]
67. Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells. Won SH; Lee HJ; Jeong SJ; Lü J; Kim SH Phytother Res; 2012 May; 26(5):669-74. PubMed ID: 21997969 [TBL] [Abstract][Full Text] [Related]
68. [Inhibition of the expression of prostate specific antigen by curcumin]. Yang L; Zhang LY; Chen WW; Kong F; Zhang PJ; Hu XY; Zhang JY; Cui FA Yao Xue Xue Bao; 2005 Sep; 40(9):800-3. PubMed ID: 16342680 [TBL] [Abstract][Full Text] [Related]
69. Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells. Lu S; Tsai SY; Tsai MJ Endocrinology; 1999 Nov; 140(11):5054-9. PubMed ID: 10537131 [TBL] [Abstract][Full Text] [Related]
70. Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide. Madarová J; Lukesová M; Hlobilková A; Riháková P; Murray PG; Student V; Vojtsek B; Kolár Z Neoplasma; 2001; 48(5):419-24. PubMed ID: 11845989 [TBL] [Abstract][Full Text] [Related]
71. Androgen responsive and refractory prostate cancer cells exhibit distinct curcumin regulated transcriptome. Thangapazham RL; Shaheduzzaman S; Kim KH; Passi N; Tadese A; Vahey M; Dobi A; Srivastava S; Maheshwari RK Cancer Biol Ther; 2008 Sep; 7(9):1427-35. PubMed ID: 18719366 [TBL] [Abstract][Full Text] [Related]
72. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells. Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979 [TBL] [Abstract][Full Text] [Related]
73. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer. Dulinska-Litewka J; McCubrey JA; Laidler P Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951 [TBL] [Abstract][Full Text] [Related]
74. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. Kan SF; Huang WJ; Lin LC; Wang PS Int J Cancer; 2004 Jul; 110(5):641-51. PubMed ID: 15146552 [TBL] [Abstract][Full Text] [Related]
75. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397 [TBL] [Abstract][Full Text] [Related]
76. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. Kim J; Park H; Im JY; Choi WS; Kim HS Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072 [TBL] [Abstract][Full Text] [Related]
77. Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells. Zhang X; Chen M; Zou P; Kanchana K; Weng Q; Chen W; Zhong P; Ji J; Zhou H; He L; Liang G BMC Cancer; 2015 Nov; 15():866. PubMed ID: 26546056 [TBL] [Abstract][Full Text] [Related]
78. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153 [TBL] [Abstract][Full Text] [Related]
79. Androgen receptor-dependent and -independent mechanisms mediate Ganoderma lucidum activities in LNCaP prostate cancer cells. Zaidman BZ; Wasser SP; Nevo E; Mahajna J Int J Oncol; 2007 Oct; 31(4):959-67. PubMed ID: 17786330 [TBL] [Abstract][Full Text] [Related]
80. Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway. Li X; Li T; Chen D; Zhang P; Song Y; Zhu H; Xiao Y; Xing Y Oncol Rep; 2016 Jan; 35(1):584-92. PubMed ID: 26534764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]